ERαは,腫瘍細胞の生存と薬剤耐性を維持するRNA結合タンパク質である
Yichen Xu1, Peiwei Huangyang2, Ying Wang2
1Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA; Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Cell
|September 24, 2021
まとめ
エストロゲン受容体アルファ (ERα) は乳がんの誘発因子として知られており,意外にもRNA結合タンパク質として機能する. この新しいRNA結合の役割は,DNA結合とは別に,がんの進行とタモキシフェン耐性において極めて重要です.
科学分野:
- 分子生物学
- 癌 生物学
- ゲノミクス
背景:
- エストロゲン受容体アルファ (ERα) は乳がんの70%以上で重要な要因です.
- ERαは遺伝子発現を調節する転写因子として広範に研究されている.
研究 の 目的:
- 転写因子としての役割を超えたERαの非正規的機能を調査する.
- 乳がんの進行と薬剤耐性におけるERαのRNA結合活動の役割を明らかにする.
主な方法:
- ERα結合RNAを識別するための全ゲノムクロスリンク免疫降水 (CLIP) 配列化.
- ERαに関連したmRNAの影響を評価する機能的CRISPR干渉 (CRISPRi) スクリーン.
- スプライシングとトランスレーションを含むRNA代謝におけるERαの役割の分析.
主要な成果:
- ERαはDNA結合活動とは独立して強力な非正規のRNA結合タンパク質として機能する.
- ERαに関連したmRNAは,がん細胞の健康状態とストレス反応に不可欠です.
- ERαRNA結合は,XBP1の代替スプライシングとeIF4G2およびMCL1mRNAの翻訳を調節する.
- このRNA結合機能は,がん細胞のストレス下での生存とタモキシフェン抵抗に寄与する.
結論:
- ERαは,重要なRNA結合能力を持つ多面的なタンパク質です.
- ERαのRNA結合活動は,癌の発生と治療応答を促す転写後の調節における新しいメカニズムを表しています.
- ERαのRNA結合機能をターゲットにすることで,乳がんに対する新しい治療戦略が提供される可能性があります.
さらに関連する動画
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
7.0K
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
13.9K
関連する概念動画
01:53RNA Stability
34.2K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
34.2K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:38Mitogens and the Cell Cycle
7.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
02:23Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
02:38The Ras Gene
6.6K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.6K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K